Positive inotropic therapy: an update and new agents.
Leier
C V
CV
Division of Cardiology, Ohio State University, Columbus, USA.
D000284:Administration, Oral; D001011:Aorta / Q000187:drug effects / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D002395:Catecholamines / Q000627:therapeutic use; D002396:Catechols / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007473:Ion Channels / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D014655:Vascular Resistance; D016276:Ventricular Function
D002316:Cardiotonic Agents; D002395:Catecholamines; D002396:Catechols; D007473:Ion Channels; D010726:Phosphodiesterase Inhibitors; D002118:Calcium